Cleared Traditional

K780173 - LYPOPROTEIN CHOLESTEROL TEST KIT

K780173 is the FDA 510(k) clearance for LYPOPROTEIN CHOLESTEROL TEST KIT by Environmental Chemical Specialties. It is a Class 1 Chemistry device (product code JHM) cleared through the Traditional 510(k) pathway after a 90-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1978
Decision
90d
Days
Class 1
Risk

K780173 is an FDA 510(k) clearance for the LYPOPROTEIN CHOLESTEROL TEST KIT. Classified as Colorimetric Method, Lipoproteins (product code JHM), Class I - General Controls.

Submitted by Environmental Chemical Specialties (Mchenry, US). The FDA issued a Cleared decision on May 3, 1978 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1475 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Environmental Chemical Specialties devices

Submission Details

510(k) Number K780173 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 1978
Decision Date May 03, 1978
Days to Decision 90 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 88d · This submission: 90d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JHM Colorimetric Method, Lipoproteins
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1475
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.